Should You Buy Salesforce Stock Instead of Oracle Stock? | CRM Stock Analysis | ORCL Stock Analysis
2 extracted signals · 1 resolved · 0 still active
Parkev Tatevosian, CFAIndependent analyst profile- Source published
- 06 Jul 2026, 12:45 UTC
- Recorded by Tahlil Plus
- 06 Jul 2026, 13:25 UTC

AI-generated source summary
The analysis compares Salesforce (CRM) and Oracle (ORCL) based on financial metrics. Both stocks have seen significant price declines, with CRM down 36.91% and ORCL down 28.03% year-to-date. Oracle's revenue growth is accelerating, reaching $67.36B in the trailing twelve months (TTM), while Salesforce's revenue growth is slowing, with $42.84B TTM. Oracle's operating margin (33.32% TTM) is higher and has been improving, whereas Salesforce's operating margin (21.87% TTM) saw a dip before recovering. Oracle's CAPEX to revenue ratio (0.826) is substantially higher than Salesforce's (0.013), indicating more aggressive capital expenditure, possibly for data centers supporting AI initiatives. Both companies are considered undervalued based on discounted cash flow models, with Salesforce's intrinsic value estimated at $290.44 and Oracle's at $219.42. Despite both trading at their cheapest valuations in years, Salesforce is presented as the better buy due to its cheaper valuation and perceived stronger positioning for AI integration. The analysis is based on fundamental financial data and a 1-day timeframe.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
2 eligible signals linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
Parkev Tatevosian, CFA
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

